# Sanderling Ventures: portfolio, investments and team

> Sanderling Ventures is a vc firm based in United States. 64 investments on record, latest Aug 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/sanderling-ventures (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Sanderling Ventures

Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet New fund, Jul 2016 VC firm

Seed Series A Series B Biomedical Small Molecule Therapeutics Biologics

Follow Sanderling Ventures and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fsanderling-ventures)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 64 on record

Since the last cheque **2642** days **00** hrs **00** min **00** sec

Median round **$31M** Rounds led **0 of 64** Sole investor **8 rounds** Exits **5 from the portfolio** Mostly in **United States, 89%**

Pitch Sanderling Ventures

## Sanderling Ventures highlights

- 01 64 rounds on record
- 02 Mostly Series C and Series B: 48% of its rounds
- 03 Sole investor in 8 rounds, median $4.0M
- 04 5 exits from the portfolio

## What they do

> Dedicated to early-stage biomedical financing and active management From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Biomedical Small Molecule Therapeutics Biologics
- **Based in:** San Mateo, United States
- **Cold pitches:** Not accepted

## The record

Every round we can evidence, newest first **64 appearances**

- **2019** 1 round
- **Aug** **[Glycomine](https://millionrounds.com/company/glycomine)** Series B · US · FinSMEs **$33M** With 4 others
- **2018** 1 round
- **Nov** **[ViaCyte](https://millionrounds.com/company/viacyte)** Series D · US · Viacyte **$80M** With 2 others
- **2017** 2 rounds
- **Nov** **[Glycomine](https://millionrounds.com/company/glycomine)** Series A · US · FinSMEs **$12M** Sole investor
- **Jul** **[PreciThera](https://millionrounds.com/company/precithera)** Series A · CA · FinSMEs **$29M** With 4 others
- **2015** 1 round
- **Jan** **[Lineagen](https://millionrounds.com/company/lineagen)** Series C · US **$12M** With 9 others
- **2013** 3 rounds
- **Dec** **[Lineagen](https://millionrounds.com/company/lineagen)** Series C · US **$3.5M** With 7 others
- **Jul** **[ViaCyte](https://millionrounds.com/company/viacyte)** Series C · US · pehub.com **$11M** With 1 other
- **Feb** **[Sotera Wireless](https://millionrounds.com/company/sotera-wireless)** Series D · US · pevc.dowjones.com **$15M** With 6 others
- **2012** 2 rounds
- **Sept** **[Torax Medical](https://millionrounds.com/company/torax-medical)** Series D · US · finsmes.com **$30M** With 5 others
- **Apr** **[TheraVida](https://millionrounds.com/company/theravida)** Venture · US **$1.0M** Sole investor
- **2011** 4 rounds
- **Dec** **[Sotera Wireless](https://millionrounds.com/company/sotera-wireless)** Series D · US · prnewswire.com **$12M** With 3 others
- **Nov** **[Lineagen](https://millionrounds.com/company/lineagen)** Series B · US **$16M** With 3 others
- **Feb** **[Chimerix](https://millionrounds.com/company/chimerix)** Series F · US · chimerix-inc.com **$45M** With 7 others
- **Jan** **[Lineagen](https://millionrounds.com/company/lineagen)** Series B · US · finsmes.com **$15M** With 3 others
- **2010** 8 rounds
- **Oct** **[InfraReDx](https://millionrounds.com/company/infraredx)** Series D · US · masshightech.com **$21M** Sole investor
- **Aug** **[Lineagen](https://millionrounds.com/company/lineagen)** Series A · US · businesswire.com **$11M** With 3 others
- **Aug** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series E · CA · onbiovc.com **$8.0M** With 1 other
- **Jul** **[TheraVida](https://millionrounds.com/company/theravida)** Debt · US · deals.venturebeat.com **$3.6M** Sole investor
- **Apr** **[Sotera Wireless](https://millionrounds.com/company/sotera-wireless)** Series C · US · pehub.com **$11M** With 3 others
- **Apr** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series D · CA · fiercebiotech.com **$16M** With 1 other
- **Jan** **[Neomend](https://millionrounds.com/company/neomend)** Series D · US · finsmes.com **$30M** With 4 others
- **Jan** **[Endocyte](https://millionrounds.com/company/endocyte)** Series C · US · onbiovc.com **$26M** With 4 others
- **2009** 5 rounds
- **Dec** **[CalciMedica](https://millionrounds.com/company/calcimedica)** Series C · US · finsmes.com **$12M** With 2 others
- **Nov** **[Trinity Biosystems](https://millionrounds.com/company/trinity-biosystems)** Debt · US · deals.venturebeat.com **$7.5M** With 4 others
- **Aug** **[Chimerix](https://millionrounds.com/company/chimerix)** Series E · US · fiercebiotech.com **$16M** With 3 others
- **Jan** **[Axikin Pharmaceuticals](https://millionrounds.com/company/axikin-pharmaceuticals)** Series A · US · reuters.com **$3.0M** With 1 other
- **Jan** **[CalciMedica](https://millionrounds.com/company/calcimedica)** Series C · US · onbiovc.com **$4.0M** With 2 others
- **2008** 8 rounds
- **Dec** **[Lineagen](https://millionrounds.com/company/lineagen)** Venture · US **$5.8M** With 2 others
- **Jul** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series C · CA · siliconindia.com **$38M** With 12 others
- **Jun** **[Actimis Pharmaceuticals](https://millionrounds.com/company/actimis-pharmaceuticals)** Venture · US **$9.6M** Sole investor
- **Jun** **[Asteres](https://millionrounds.com/company/asteres)** Venture · US · xconomy.com **$4.0M** Sole investor
- **Mar** Series B · bio-medicine.org **$20M** With 3 others
- **Mar** **[Sotera Wireless](https://millionrounds.com/company/sotera-wireless)** Series B · US · soterawireless.com **$20M** With 3 others
- **Feb** **[CalciMedica](https://millionrounds.com/company/calcimedica)** Series B · US · sec.gov **$5.5M** With 1 other
- **Jan** **[Taligen Therapeutics](https://millionrounds.com/company/taligen-therapeutics)** Series B · US · taligentherapeutics.com **$65M** With 3 others
- **2007** 8 rounds
- **Nov** **[Asteres](https://millionrounds.com/company/asteres)** Series C · US · venturedeal.com **$4.0M** With 2 others
- **Jul** Series C · novocell.com **$25M** With 3 others
- **Jul** **[ViaCyte](https://millionrounds.com/company/viacyte)** Series C · US · novocell.com **$25M** With 3 others
- **Jul** **[Neomend](https://millionrounds.com/company/neomend)** Series C · US **$6.0M** With 1 other
- **May** **[Naviscan](https://millionrounds.com/company/naviscan)** Series C · US **$15M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **5 named**

FA **Fred A. Middleton** Managing Director of the General Partner i Filing they signed

FA **Frederick Alexander Middleton** Managing Director i Form ADV

PC **Peter C.M. McWilliams** Managing Director of the General Partner i Filing they signed

RG **Robert G. McNeil** Managing Director of the General Partner i Filing they signed

TC **Timothy Curtis Mills** Managing Director of the General Partner i Filing they signed

We also hold **13** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$161M** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Sanderling Management Company, LLC
- **SEC number:** CRD 162520

## What they claim to have backed

From their own portfolio page (on their website)

**14** of 41 we have independently watched raise

[Altor BioScience](https://millionrounds.com/company/immunitybio)[Asteres](https://millionrounds.com/company/asteres)[CalciMedica](https://millionrounds.com/company/calcimedica)[Cardionet](https://millionrounds.com/company/cardionet)[Cylene](https://millionrounds.com/company/senhwa-biosciences)[Endocyte](https://millionrounds.com/company/endocyte)[Glycomine](https://millionrounds.com/company/glycomine)[LineaGen](https://millionrounds.com/company/bionano-genomics)[Metavention](https://millionrounds.com/company/metavention)[Naviscan](https://millionrounds.com/company/naviscan)[Soterawireless](https://millionrounds.com/company/sotera-wireless)[Stereotaxis](https://millionrounds.com/company/stereotaxis)[Theravida](https://millionrounds.com/company/theravida)[ViaCyte](https://millionrounds.com/company/viacyte) Actimis Aderis Advanced Cardiovascular Artielle BioSpace Carecentric Dalcorpharma Dendreon DepoTech Digirad GeminX ISTA InterMune Kadmus Liphorus NeoMend Pacira Pulsar Regeneron Stentor Taligen Theregen Therillia Torax Ventritex Vical Xoma

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **5 in all**

**[InfraReDx](https://millionrounds.com/company/infraredx)** Bought by Nipro Corporation **Undisclosed** Oct 2015

**[Neomend](https://millionrounds.com/company/neomend)** Bought by C. R. Bard **$140M** Oct 2012

**[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Bought by [Cephalon](https://millionrounds.com/fund/cephalon) **$525M** Mar 2011

**[Taligen Therapeutics](https://millionrounds.com/company/taligen-therapeutics)** Bought by [Alexion Pharmaceuticals](https://millionrounds.com/fund/alexion-pharmaceuticals) **$111M** Jan 2011

**[Actimis Pharmaceuticals](https://millionrounds.com/company/actimis-pharmaceuticals)** Bought by [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) **$515M** Jun 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**Raised**

a new fund in Jul 2016

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$31M** the round, not its cheque Alone, median **$4.0M**

Led 0 of 64 rounds **0%**

- **Sole investor:** 8 rounds
- **Last cheque:** Aug 2019
- **Exits:** 5 from the portfolio

Rounds by stage said on their site

- Series C *17*
- Series B said *12*
- Series A said *11*
- Venture *9*
- Series D *9*
- Debt *2*
- Seed said *-*

Cheques by year Led Joined

2002 2019

Often in the room with

- [Asset Management Ventures](https://millionrounds.com/fund/asset-management-ventures) 8
- [Intel Capital](https://millionrounds.com/fund/intel-capital) 6
- [Mesa Verde Venture Partners](https://millionrounds.com/fund/mesa-verde-venture-partners) 6
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 5
- [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) 5
- [PrairieGold Venture Partners](https://millionrounds.com/fund/prairiegold-venture-partners) 5

**Pitching Sanderling Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Sanderling Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**Asset Management Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/asset-management-ventures)[**Intel Capital** Corporate VC **6** rounds together](https://millionrounds.com/fund/intel-capital)[**Mesa Verde Venture Partners** VC firm **6** rounds together](https://millionrounds.com/fund/mesa-verde-venture-partners)[**Alta Partners** VC firm **5** rounds together](https://millionrounds.com/fund/alta-partners)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **5** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**PrairieGold Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/prairiegold-venture-partners)[**Pacific Horizon Ventures** Growth equity **4** rounds together](https://millionrounds.com/fund/pacific-horizon-ventures)[**Qualcomm** Corporate VC **4** rounds together](https://millionrounds.com/fund/qualcomm)[**vSpring Capital** VC firm **4** rounds together](https://millionrounds.com/fund/vspring-capital)[**Blue Chip Venture Company** VC firm **3** rounds together](https://millionrounds.com/fund/blue-chip-venture-company)[**Burrill & Company** VC firm **3** rounds together](https://millionrounds.com/fund/burrill-and-company)[**Canaan** VC firm **3** rounds together](https://millionrounds.com/fund/canaan-partners)

## Recently backed

The latest companies Sanderling Ventures put money into.

[**Glycomine** $33M · Aug 2019](https://millionrounds.com/company/glycomine)[**ViaCyte** $80M · Nov 2018](https://millionrounds.com/company/viacyte)[**PreciThera** $29M · Jul 2017](https://millionrounds.com/company/precithera)

## Quick answers about Sanderling Ventures

### What does Sanderling Ventures invest in?

Sanderling Ventures invests most often at Series C and Series B (48% of the rounds on record), in sectors such as Biomedical, Small Molecule Therapeutics and Biologics.

### How active is Sanderling Ventures?

64 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.

### What has Sanderling Ventures invested in recently?

Its most recent investments on record: Glycomine (Series B, Aug 2019), ViaCyte (Series D, Nov 2018) and PreciThera (Series A, Jul 2017).

### How big are Sanderling Ventures's cheques?

The median round it joins is $31M.

### Does Sanderling Ventures lead rounds?

Rarely, if at all: none of its 64 investments on record names it as the lead.

### Where does Sanderling Ventures invest?

Most of the companies it backs are in the United States (89%) and Canada (11%).

### Is Sanderling Ventures investing now?

No investments in the last 12 months; the latest was in Aug 2019.

### Who does Sanderling Ventures invest alongside?

Most often Asset Management Ventures (8 rounds together), Intel Capital (6 rounds together) and Mesa Verde Venture Partners (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=sanderling-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=sanderling-ventures)